Global Footprint Sampled operates labs in the United States and the United Kingdom with ISO and ISO 9001 accreditation, plus licensing by leading regulatory bodies. This global footprint and compliance posture can reduce regulatory friction for multinational studies and ensure high-integrity sample handling.

End-to-End Biobanking The company provides an integrated suite including storage, sample management, multiomics, stem cell processing, and custom clinical kitting. This enables customers to source and process samples from a single provider, accelerating timelines and simplifying vendor management.

Partnerships and Workflows Recent collaborations with AutoGen for next-generation nucleic acid extraction and multiomic workflows, along with EBISC shipping support for iPSC resources, indicate a growing ecosystem. This presents opportunities to co-develop workflows, expand offerings, and cross-sell integrated services.

Scale and Reliability With a proven capability to handle substantial sample volumes and a mature quality system, Sampled is positioned to win enterprise contracts with pharma, biotech, and CROs seeking reliable, long-term partnerships.

Market Differentiation Competitive advantages include end-to-end capabilities, stem cell processing, clinical kitting, and global compliant biobanking. Target audiences include biotechs, CROs, and academic researchers needing turnkey sample solutions and iPSC resources.